Retatrutide 40mg Pen UK (Alluvi)

£159.99

Retatrutide 40mg Pen UK

Retatrutide 40mg Injection Pen refers to a product marketed as containing retatrutide, also known as LY3437943. Retatrutide is a  triple receptor agonist involving GIP, GLP-1 and glucagon pathways and is currently being studied in clinical research. This page is provided for R&D and research-information purposes only, not for human use or self-administration.